Please login to the form below

Not currently logged in
Email:
Password:

REGN-COV2

This page shows the latest REGN-COV2 news and features for those working in and with pharma, biotech and healthcare.

FDA grants emergency use for Lilly’s COVID-19 antibody drug combination

FDA grants emergency use for Lilly’s COVID-19 antibody drug combination

On a key clinical endpoint, REGN-COV2 treatment reduced COVID-19-related medical visits by 57% until day 29. ... Treatment with REGN-COV2 also reduced COVID-19-related medical visits by 72% in patients with one or more risk factors.

Latest news

More from news
Approximately 6 fully matching, plus 10 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Langland

Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...